- Re-focusing on Getting Fit? Heart Experts Offer These Tips
- AHA News: Not Just Bad Shoes and Sore Muscles – She Had Peripheral Artery Disease
- Scientists Find Clues to Why AstraZeneca’s Vaccine May Cause Clots
- Stressed, Exhausted: Frontline Workers Faced Big Mental Strain in Pandemic
- Supply of J&J COVID Vaccine to Drop 86 Percent Next Week
- Health Highlights: April 9, 2021
- Nearly Half of U.S. Veterans Cited ‘Personal Growth’ During Pandemic: Survey
- Bright Side: Sunnier Areas Have Lower COVID-19 Death Rates
- Pandemic Has Put Many Clinical Trials on Hold
- Non-Emergency Surgeries Are Rebounding, But Backlogs Remain
Overweight Men May Face Higher Death Risk From Prostate Cancer: Study
TUESDAY, Nov. 12Men who are overweight or obese when they’re diagnosed with prostate cancer face a higher risk of dying from the disease, a new study suggests.
Researchers looked at more than 750 prostate cancer patients who had surgery to remove their prostate and surrounding tissue.
Patients who eventually died from prostate cancer were 50 percent more likely to be overweight or obese at the time of diagnosis than those who did not die from the disease. The association between overweight/obesity and increased risk of death was highest among men with more aggressive types of prostate cancer.
The study was published recently in the journal Obesity Research & Clinical Practice.
“We found among patients undergoing surgical treatment for prostate cancer, weight at time of diagnosis is more strongly correlated with prostate cancer survival than many other factors researchers have studied in the past, including some prostate cancer treatments,” study lead author Reina Haque, a researcher at Kaiser Permanente Southern California, said in a Kaiser news release.
The study found an association between being overweight when diagnosed with prostate cancer and a higher risk of death, but it did not prove cause-and-effect.
“Moving forward, we are hoping future studies will examine the effect of weight loss and other lifestyle modifications on prostate cancer mortality,” Haque said.
Additional studies are needed to determine if the study findings also apply to prostate cancer patients who have other treatments, such as radiation or hormone therapy, the researchers said.
More information
The U.S. National Cancer Institute has more about prostate cancer.
Source: HealthDay
